Commonwealth Equity Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $98M | Sell |
3,488,515
-153,523
| -4% | -$4.09M | 0.14% | 143 |
|
|
2025
Q4 | $90.7M | Sell |
3,642,038
-161,468
| -4% | -$4.07M | 0.12% | 157 |
|
|
2025
Q3 | $96.9M | Sell |
3,803,506
-380,452
| -9% | -$9.39M | 0.13% | 155 |
|
|
2025
Q2 | $101M | Sell |
4,183,958
-418,518
| -9% | -$9.76M | 0.13% | 147 |
|
|
2025
Q1 | $117M | Buy |
4,602,476
+117,370
| +3% | +$3.07M | 0.17% | 118 |
|
|
2024
Q4 | $119M | Sell |
4,485,106
-208,017
| -4% | -$5.64M | 0.17% | 106 |
|
|
2024
Q3 | $136M | Buy |
4,693,123
+18,198
| +0.4% | +$531K | 0.21% | 93 |
|
|
2024
Q2 | $131M | Buy |
4,674,925
+119,109
| +3% | +$3.28M | 0.21% | 87 |
|
|
2024
Q1 | $126M | Buy |
4,555,816
+266,221
| +6% | +$7.39M | 0.21% | 90 |
|
|
2023
Q4 | $123M | Sell |
4,289,595
-333,757
| -7% | -$10.1M | 0.23% | 83 |
|
|
2023
Q3 | $153M | Buy |
4,623,352
+7,743
| +0.2% | +$274K | 0.32% | 57 |
|
|
2023
Q2 | $169M | Buy |
4,615,609
+151,295
| +3% | +$5.89M | 0.34% | 50 |
|
|
2023
Q1 | $182K | Buy |
4,464,314
+87,173
| +2% | +$3.77M | 0.38% | 43 |
|
|
2022
Q4 | $224M | Buy |
4,377,141
+29,577
| +0.7% | +$1.42M | 0.54% | 29 |
|
|
2022
Q3 | $190M | Sell |
4,347,564
-58,498
| -1% | -$2.84M | 0.49% | 33 |
|
|
2022
Q2 | $231M | Buy |
4,406,062
+68,267
| +2% | +$3.48M | 0.6% | 21 |
|
|
2022
Q1 | $225M | Buy |
4,337,795
+9,988
| +0.2% | +$518K | 0.51% | 29 |
|
|
2021
Q4 | $256M | Buy |
4,327,807
+129,783
| +3% | +$6.43M | 0.58% | 28 |
|
|
2021
Q3 | $181M | Buy |
4,198,024
+87,553
| +2% | +$3.88M | 0.45% | 38 |
|
|
2021
Q2 | $161M | Buy |
4,110,471
+157,678
| +4% | +$6.13M | 0.41% | 47 |
|
|
2021
Q1 | $143M | Buy |
3,952,793
+209,804
| +6% | +$7.45M | 0.41% | 49 |
|
|
2020
Q4 | $138M | Buy |
3,742,989
+8,929
| +0.2% | +$328K | 0.41% | 48 |
|
|
2020
Q3 | $130M | Buy |
3,734,060
+365,011
| +11% | +$12.8M | 0.44% | 43 |
|
|
2020
Q2 | $105M | Buy |
3,369,049
+218,092
| +7% | +$7.41M | 0.39% | 50 |
|
|
2020
Q1 | $97.6M | Buy |
3,150,957
+27,108
| +0.9% | +$924K | 0.45% | 45 |
|
|
2019
Q4 | $116M | Buy |
3,123,849
+138,549
| +5% | +$4.94M | 0.44% | 48 |
|
|
2019
Q3 | $102M | Buy |
2,985,300
+16,556
| +0.6% | +$602K | 0.43% | 49 |
|
|
2019
Q2 | $122M | Buy |
2,968,744
+20,333
| +0.7% | +$807K | 0.54% | 34 |
|
|
2019
Q1 | $119M | Buy |
2,948,411
+97,254
| +3% | +$3.89M | 0.55% | 32 |
|
|
2018
Q4 | $118M | Buy |
2,851,157
+14,561
| +0.5% | +$604K | 0.63% | 33 |
|
|
2018
Q3 | $119M | Sell |
2,836,596
-43,847
| -2% | -$1.69M | 0.57% | 33 |
|
|
2018
Q2 | $98.3M | Buy |
2,880,443
+69,896
| +2% | +$2.39M | 0.51% | 36 |
|
|
2018
Q1 | $94.6M | Buy |
2,810,547
+101,467
| +4% | +$3.49M | 0.51% | 36 |
|
|
2017
Q4 | $93.1M | Buy |
2,709,080
+60,968
| +2% | +$2.08M | 0.51% | 37 |
|
|
2017
Q3 | $89.7M | Buy |
2,648,112
+45,291
| +2% | +$1.46M | 0.54% | 37 |
|
|
2017
Q2 | $82.9M | Sell |
2,602,821
-37,300
| -1% | -$1.18M | 0.53% | 39 |
|
|
2017
Q1 | $85.7M | Buy |
2,640,121
+155,412
| +6% | +$4.9M | 0.57% | 32 |
|
|
2016
Q4 | $76.6M | Buy |
2,484,709
+107,268
| +5% | +$3.27M | 0.57% | 35 |
|
|
2016
Q3 | $76.4M | Buy |
2,377,441
+20,360
| +0.9% | +$681K | 0.61% | 31 |
|
|
2016
Q2 | $78.7M | Buy |
2,357,081
+46,205
| +2% | +$1.47M | 0.66% | 28 |
|
|
2016
Q1 | $65M | Buy |
2,310,876
+128,988
| +6% | +$3.68M | 0.58% | 32 |
|
|
2015
Q4 | $66.8M | Buy |
2,181,888
+118,869
| +6% | +$3.74M | 0.63% | 29 |
|
|
2015
Q3 | $61.5M | Buy |
2,063,019
+193,473
| +10% | +$6.2M | 0.65% | 27 |
|
|
2015
Q2 | $59.5M | Buy |
1,869,546
+46,034
| +3% | +$1.5M | 0.59% | 26 |
|
|
2015
Q1 | $60.2M | Buy |
1,823,512
+77,935
| +4% | +$2.48M | 0.62% | 27 |
|
|
2014
Q4 | $51.6M | Buy |
1,745,577
+17,995
| +1% | +$516K | 0.58% | 32 |
|
|
2014
Q3 | $48.5M | Buy |
1,727,582
+55,682
| +3% | +$1.56M | 0.59% | 31 |
|
|
2014
Q2 | $47.1M | Buy |
1,671,900
+73,018
| +5% | +$2.08M | 0.57% | 30 |
|
|
2014
Q1 | $48.7M | Buy |
1,598,882
+96,141
| +6% | +$2.87M | 0.67% | 27 |
|
|
2013
Q4 | $43.7M | Buy |
1,502,741
+39,385
| +3% | +$1.15M | 0.63% | 26 |
|
|
2013
Q3 | $39.9M | Buy |
1,463,356
+62,682
| +4% | +$1.71M | 0.65% | 27 |
|
|
2013
Q2 | $37.2M | Buy |
+1,400,674
| New | +$38.7M | 0.66% | 27 |
|
Other funds holding PFE
VCM
VPM
Commonwealth Equity Services's PFE Position: Q1 2026 in Review
Commonwealth Equity Services reduced its Pfizer (PFE) stake by 4.2% in Q1 2026, selling an estimated $4.09M and leaving 3,488,515 shares worth $98M. The position accounts for 0.14% of the portfolio, ranked #143.
Commonwealth Equity Services first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $256M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Commonwealth Equity Services held 3,488,515 shares of Pfizer worth $98M as of Q1 2026.
- Commonwealth Equity Services sold 153,523 Pfizer shares in Q1 2026, an estimated $4.09M.
- Pfizer made up 0.14% of Commonwealth Equity Services's portfolio in Q1 2026, its #143 holding.
- Commonwealth Equity Services first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Commonwealth Equity Services's Pfizer position peaked at $256M in Q4 2021.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.